MEF2C (pS387) Antibody
Référence MBS8584037-0,1mL-HRP
Conditionnement : 0.1mL(HRP)
Marque : MyBiosource
MEF2C Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS8584037MBS8584037 is an antibody targeting MEF2C. Also known as MEF2C (pS387) Antibody. Reactive in Human, Rat, Monkey, Pig. Host: Rabbit. Rabbit polyclonal antibody to MEF2C (pS387) More details
Product Overview
Online Datasheet in PDFProduct Name
MEF2C, Polyclonal Antibody
Full Product Name
MEF2C (pS387) Antibody
Product Gene Name
anti-MEF2C antibody
Product Synonym Names
Myocyte-specific enhancer factor 2C
Clonality
Polyclonal
Isotype
IgG
Host
Rabbit
Species Reactivity
Human, Rat, Monkey, Pig
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH7.3, 30% glycerol, and 0.01% sodium azide.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Specificity
Recognizes endogenous levels of MEF2C with a site at pS387 protein.
Molecular Weight
51,221 Da
Chromosome Location
Chromosome: 5; NC_000005.9 (88014058..88199922, complement). Location: 5q14
OMIM
600662
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human MEF2C with a site at pS387. The exact sequence is proprietary.
Product Categories/Family for anti-MEF2C antibody
Primary Antibody
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for anti-MEF2C antibody
Western Blot (WB), Immunohistochemistry (IHC)
Other Notes
Small volumes of anti-MEF2C antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for MEF2C. It may not necessarily be applicable to this product.
NCBI Official Full Name
myocyte-specific enhancer factor 2C isoform 2
NCBI Official Synonym Full Names
myocyte enhancer factor 2C
NCBI Official Symbol
MEF2C
NCBI Official Synonym Symbols
DEL5q14.3; C5DELq14.3
UniProt Protein Name
Myocyte-specific enhancer factor 2C
Protein Family
Myocyte-specific enhancer factor
UniProt Gene Name
MEF2C
UniProt Entry Name
MEF2C_HUMAN
NCBI Protein Information
myocyte-specific enhancer factor 2C; MADS box transcription enhancer factor 2, polypeptide C
NCBI Summary for MEF2C
This locus encodes a member of the MADS box transcription enhancer factor 2 (MEF2) family of proteins, which play a role in myogenesis. The encoded protein, MEF2 polypeptide C, has both trans-activating and DNA binding activities. This protein may play a role in maintaining the differentiated state of muscle cells. Mutations and deletions at this locus have been associated with severe mental retardation, stereotypic movements, epilepsy, and cerebral malformation. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2010]
Show more UniProt Comments for MEF2C
MEF2C: transcription factor of the MADS family which binds specifically to the MEF2 element present in the regulatory regions of many muscle-specific genes. May be involved in myogenesis, neurogenesis and in the development of cortical architecture. Three splice-variant isoforms have been described.
Protein type: DNA-binding; Transcription factor
Chromosomal Location of Human Ortholog: 5q14.3
Cellular Component: nucleoplasm; protein complex; intracellular membrane-bound organelle; cytoplasm; nuclear speck; nucleus; cytosol
Molecular Function: protein binding; miRNA binding; transcription activator binding; DNA binding; AT DNA binding; protein heterodimerization activity; histone deacetylase binding; chromatin binding; transcription factor activity
Biological Process: cardiac muscle hypertrophy; muscle development; nerve growth factor receptor signaling pathway; positive regulation of transcription, DNA-dependent; heart development; regulation of neurotransmitter secretion; stress-activated MAPK cascade; regulation of synaptic plasticity; toll-like receptor 3 signaling pathway; toll-like receptor 5 signaling pathway; neuron differentiation; positive regulation of MAP kinase activity; B cell receptor signaling pathway; regulation of neuron apoptosis; negative regulation of ossification; positive regulation of B cell proliferation; chondrocyte differentiation; negative regulation of neuron apoptosis; toll-like receptor 4 signaling pathway; positive regulation of cardiac muscle cell proliferation; endochondral ossification; nervous system development; skeletal muscle development; monocyte differentiation; response to virus; myotube differentiation; positive regulation of skeletal muscle development; muscle cell fate determination; toll-like receptor 2 signaling pathway; muscle cell differentiation; regulation of synaptogenesis; neuron development; positive regulation of transcription from RNA polymerase II promoter; smooth muscle cell differentiation; toll-like receptor 9 signaling pathway; B cell proliferation; transcription from RNA polymerase II promoter; regulation of synaptic transmission, glutamatergic; apoptosis; neuron migration; ventricular cardiac muscle cell differentiation; regulation of synaptic activity; negative regulation of transcription from RNA polymerase II promoter; palate development; toll-like receptor 10 signaling pathway; learning and/or memory; B cell homeostasis; regulation of transcription, DNA-dependent; melanocyte differentiation; regulation of megakaryocyte differentiation; germinal center formation; neural crest cell differentiation; heart looping; negative regulation of epithelial cell proliferation; blood vessel development; MyD88-independent toll-like receptor signaling pathway; MAPKKK cascade; embryonic viscerocranium morphogenesis; positive regulation of bone mineralization; humoral immune response; regulation of germinal center formation; positive regulation of myoblast differentiation; osteoblast differentiation; MyD88-dependent toll-like receptor signaling pathway; positive regulation of osteoblast differentiation; neuron morphogenesis during differentiation; toll-like receptor signaling pathway; innate immune response; positive regulation of muscle cell differentiation; blood vessel remodeling; platelet formation; regulation of excitatory postsynaptic membrane potential; positive regulation of neuron differentiation
Disease: Mental Retardation, Autosomal Dominant 20
Show more Protein type: DNA-binding; Transcription factor
Chromosomal Location of Human Ortholog: 5q14.3
Cellular Component: nucleoplasm; protein complex; intracellular membrane-bound organelle; cytoplasm; nuclear speck; nucleus; cytosol
Molecular Function: protein binding; miRNA binding; transcription activator binding; DNA binding; AT DNA binding; protein heterodimerization activity; histone deacetylase binding; chromatin binding; transcription factor activity
Biological Process: cardiac muscle hypertrophy; muscle development; nerve growth factor receptor signaling pathway; positive regulation of transcription, DNA-dependent; heart development; regulation of neurotransmitter secretion; stress-activated MAPK cascade; regulation of synaptic plasticity; toll-like receptor 3 signaling pathway; toll-like receptor 5 signaling pathway; neuron differentiation; positive regulation of MAP kinase activity; B cell receptor signaling pathway; regulation of neuron apoptosis; negative regulation of ossification; positive regulation of B cell proliferation; chondrocyte differentiation; negative regulation of neuron apoptosis; toll-like receptor 4 signaling pathway; positive regulation of cardiac muscle cell proliferation; endochondral ossification; nervous system development; skeletal muscle development; monocyte differentiation; response to virus; myotube differentiation; positive regulation of skeletal muscle development; muscle cell fate determination; toll-like receptor 2 signaling pathway; muscle cell differentiation; regulation of synaptogenesis; neuron development; positive regulation of transcription from RNA polymerase II promoter; smooth muscle cell differentiation; toll-like receptor 9 signaling pathway; B cell proliferation; transcription from RNA polymerase II promoter; regulation of synaptic transmission, glutamatergic; apoptosis; neuron migration; ventricular cardiac muscle cell differentiation; regulation of synaptic activity; negative regulation of transcription from RNA polymerase II promoter; palate development; toll-like receptor 10 signaling pathway; learning and/or memory; B cell homeostasis; regulation of transcription, DNA-dependent; melanocyte differentiation; regulation of megakaryocyte differentiation; germinal center formation; neural crest cell differentiation; heart looping; negative regulation of epithelial cell proliferation; blood vessel development; MyD88-independent toll-like receptor signaling pathway; MAPKKK cascade; embryonic viscerocranium morphogenesis; positive regulation of bone mineralization; humoral immune response; regulation of germinal center formation; positive regulation of myoblast differentiation; osteoblast differentiation; MyD88-dependent toll-like receptor signaling pathway; positive regulation of osteoblast differentiation; neuron morphogenesis during differentiation; toll-like receptor signaling pathway; innate immune response; positive regulation of muscle cell differentiation; blood vessel remodeling; platelet formation; regulation of excitatory postsynaptic membrane potential; positive regulation of neuron differentiation
Disease: Mental Retardation, Autosomal Dominant 20
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-MEF2C antibody
| Reference Product | PubMed Publications |
|---|---|
| GATA4 antibody | >94 publications with MEF2C and GATA4 |
| MEF2D antibody | >44 publications with MEF2C and MEF2D |
| HDAC5 antibody | >25 publications with MEF2C and HDAC5 |
| HDAC4 antibody | >21 publications with MEF2C and HDAC4 |
| NOTCH1 antibody | >5 publications with MEF2C and NOTCH1 |
| SP1 antibody | >5 publications with MEF2C and SP1 |
| NCOA2 antibody | >3 publications with MEF2C and NCOA2 |
| SOX18 antibody | >3 publications with MEF2C and SOX18 |
| MAPK14 antibody | >2 publications with MEF2C and MAPK14 |
| TEAD1 antibody | >2 publications with MEF2C and TEAD1 |
Pathways associated with anti-MEF2C antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Activated TLR4 Signalling Pathway antibodies | Activated TLR4 Signalling Pathway Diagram |
| Adipogenesis Pathway antibodies | Adipogenesis Pathway Diagram |
| BDNF Signaling Pathway antibodies | BDNF Signaling Pathway Diagram |
| CDO In Myogenesis Pathway antibodies | CDO In Myogenesis Pathway Diagram |
| Cardiac Progenitor Differentiation Pathway antibodies | Cardiac Progenitor Differentiation Pathway Diagram |
| Circadian Clock Pathway antibodies | Circadian Clock Pathway Diagram |
| Delta-Notch Signaling Pathway antibodies | Delta-Notch Signaling Pathway Diagram |
| Developmental Biology Pathway antibodies | Developmental Biology Pathway Diagram |
| ERK/MAPK Targets Pathway antibodies | ERK/MAPK Targets Pathway Diagram |
| Endochondral Ossification Pathway antibodies | Endochondral Ossification Pathway Diagram |
Diseases associated with anti-MEF2C antibody
| Disease Name | Pubmed Publications |
|---|---|
| Hypertrophy Antibodies | >44 publications with MEF2C and Hypertrophy |
| Nervous System Diseases Antibodies | >39 publications with MEF2C and Nervous System Diseases |
| Neoplasms Antibodies | >37 publications with MEF2C and Neoplasms |
| Intellectual Disability Antibodies | >19 publications with MEF2C and Intellectual Disability |
| Disease Models, Animal Antibodies | >17 publications with MEF2C and Disease Models, Animal |
| Brain Diseases Antibodies | >17 publications with MEF2C and Brain Diseases |
| Fibrosis Antibodies | >15 publications with MEF2C and Fibrosis |
| Epilepsy Antibodies | >12 publications with MEF2C and Epilepsy |
| Necrosis Antibodies | >10 publications with MEF2C and Necrosis |
| Inflammation Antibodies | >7 publications with MEF2C and Inflammation |
Organs/Tissues associated with anti-MEF2C antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Muscle Antibodies | >318 publications with MEF2C and Muscle |
| Heart Antibodies | >229 publications with MEF2C and Heart |
| Embryonic Tissue Antibodies | >105 publications with MEF2C and Embryonic Tissue |
| Brain Antibodies | >64 publications with MEF2C and Brain |
| Vascular Antibodies | >50 publications with MEF2C and Vascular |
| Blood Antibodies | >48 publications with MEF2C and Blood |
| Bone Marrow Antibodies | >36 publications with MEF2C and Bone Marrow |
| Nerve Antibodies | >17 publications with MEF2C and Nerve |
| Connective Tissue Antibodies | >16 publications with MEF2C and Connective Tissue |
| Liver Antibodies | >11 publications with MEF2C and Liver |


